| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1153-1161, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
ML Larramendy, M Tarkkanen, C Blomqvist, M Virolainen, T Wiklund, S Asko- Seljavaara, I Elomaa and S Knuutila
Laboratory of Medical Genetics, Helsinki University Central Hospital, Finland.
DNA sequence copy number changes were studied by comparative genomic hybridization (CGH) along all chromosomes in 58 samples of malignant fibrous histiocytoma (MFH). The material consisted of 43 primary tumors (9 of myxoid and 34 of storiform-pleomorphic subtype), 13 local recurrences (2 myxoid and 11 storiform-pleomorphic), and 2 metastases (1 myxoid and 1 storiform-pleomorphic). Genetic aberrations, with a mean of 5.5 changes per sample (range, 0 to 22), were detected in 47 of 58 samples (81%). The minimal common regions of the most frequent gains were 1p31 (33%), 9q31 (29%), 5p14-pter (26%), 7q32 (24%), and 7p15-pter (22%). High-level amplifications were detected in 16 of the 58 samples (28%). High-level amplification of 13q31-qter was seen in four tumors (7%); other high-level amplifications were more sporadic. Losses of DNA sequences were less frequent than gains. The minimal common regions of the most common losses were 13q21 (21%) and 13q22 (21%). Statistically significant correlation was found between gain of 7q32 and the rates of worse metastasis-free survival (P = 0.01) and overall survival (P = 0.004). The gain of 7q32 retained its prognostic significance also in a multivariate analysis with tumor size and grade. Gain of 1p31 was associated with a trend to decreased overall survival. Gains of 5p14- pter and 9q31 and losses of 13q21 and/or 13q22 did not have any prognostic value; neither did the total number of aberrations, total number of gains, or total number of losses per sample.
This article has been cited by other articles:
 |
|
 |
|
  T Ohguri, M Hisaoka, S Kawauchi, K Sasaki, T Aoki, S Kanemitsu, A Matsuyama, Y Korogi, and H Hashimoto Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation J. Clin. Pathol., September 1, 2006; 59(9): 978 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ota, H. Tagawa, S. Karnan, S. Tsuzuki, A. Karpas, S. Kira, Y. Yoshida, and M. Seto Identification and Characterization of a Novel Gene, C13orf25, as a Target for 13q31-q32 Amplification in Malignant Lymphoma Cancer Res., May 1, 2004; 64(9): 3087 - 3095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Marumoto, S. Honda, T. Hara, M. Nitta, T. Hirota, E. Kohmura, and H. Saya Aurora-A Kinase Maintains the Fidelity of Early and Late Mitotic Events in HeLa Cells J. Biol. Chem., December 19, 2003; 278(51): 51786 - 51795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-T. Dong, C. Chen, B. G. Stultz, J. T. Isaacs, and H. F. Frierson Jr. Deletion at 13q21 Is Associated with Aggressive Prostate Cancers Cancer Res., July 1, 2000; 60(14): 3880 - 3883. [Abstract] [Full Text]
|
|
|
|
|
|
T. Sakabe, T. Shinomiya, T. Mori, Y. Ariyama, Y. Fukuda, T. Fujiwara, Y. Nakamura, and J. Inazawa Identification of a Novel Gene, MASL1 within an Amplicon at 8p23.1 Detected in Malignant Fibrous Histiocytomas by Comparative Genomic Hybridization Cancer Res., February 1, 1999; 59(3): 511 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.'e. El-Rifai, M. Sarlomo-Rikala, S. Knuutila, and M. Miettinen DNA Copy Number Changes in Development and Progression in Leiomyosarcomas of Soft Tissues Am. J. Pathol., September 1, 1998; 153(3): 985 - 990. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
